Literature DB >> 24370335

Assessing depression in youth at clinical high risk for psychosis: a comparison of three measures.

Jordan E DeVylder1, Lawrence H Yang2, Jill M Harkavy-Friedman3, Neyra Azimov4, Deborah J Walder5, Cheryl M Corcoran4.   

Abstract

Depressive symptoms are prevalent among individuals at clinical high-risk (CHR) for psychosis. Prior studies have used the Beck Depression Inventory (BDI), Hamilton Depression Rating Scale (HDRS), and the "dysphoric mood" item of the Scale of Prodromal Symptoms (SOPS) to assess depressive symptoms in CHR samples. We compared the psychometric properties of these instruments in a CHR cohort, to support the selection of appropriate depressive symptoms measures in future studies and in clinical settings. Internal consistency was assessed using Cronbach's alpha. Construct validity was assessed through correlations with SOPS items that were expected or not expected to be related to depressive symptoms. Criterion validity was assessed by comparing scores between patients with and without a major depressive disorder diagnosis. We hypothesized based on the schizophrenia literature that the BDI would have superior internal consistency and discriminant validity compared to the HDRS, and that all three measures would show convergent validity and criterion validity. The BDI demonstrated superior internal consistency and construct validity in this at-risk sample. The BDI and HDRS differentiated patients with major depressive disorder, but SOPS dysphoria did not. This has implications for the choice of depression measures in future CHR studies and for the interpretation of past findings.
© 2013 Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  At-risk; Depressive symptoms; Prodrome; Psychometric; Reliability; Schizophrenia; Validity

Mesh:

Year:  2013        PMID: 24370335      PMCID: PMC3945159          DOI: 10.1016/j.psychres.2013.12.002

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  56 in total

1.  Factorial structure of the Scale of Prodromal Symptoms.

Authors:  K A Hawkins; T H McGlashan; D Quinlan; T J Miller; D O Perkins; R B Zipursky; J Addington; S W Woods
Journal:  Schizophr Res       Date:  2004-06-01       Impact factor: 4.939

2.  Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.

Authors:  Danielle A Schlosser; Sarah Jacobson; Qiaolin Chen; Catherine A Sugar; Tara A Niendam; Gang Li; Carrie E Bearden; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2011-08-08       Impact factor: 9.306

3.  Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis.

Authors:  Pim Cuijpers; Juan Li; Stefan G Hofmann; Gerhard Andersson
Journal:  Clin Psychol Rev       Date:  2010-06-18

4.  Treatment history in the psychosis prodrome: characteristics of the North American Prodrome Longitudinal Study Cohort.

Authors:  Kristin S Cadenhead; Jean Addington; Tyrone Cannon; Barbara Cornblatt; Thomas McGlashan; Diana Perkins; Larry Seidman; Ming Tsuang; Elaine Walker; Scott Woods; Robert Heinssen
Journal:  Early Interv Psychiatry       Date:  2010-08       Impact factor: 2.732

5.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial.

Authors:  G Paul Amminger; Miriam R Schäfer; Konstantinos Papageorgiou; Claudia M Klier; Sue M Cotton; Susan M Harrigan; Andrew Mackinnon; Patrick D McGorry; Gregor E Berger
Journal:  Arch Gen Psychiatry       Date:  2010-02

6.  The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample.

Authors:  T J Miller; R B Zipursky; D Perkins; J Addington; S W Woods; K A Hawkins; R Hoffman; A Preda; I Epstein; D Addington; S Lindborg; E Marquez; M Tohen; A Breier; T H McGlashan
Journal:  Schizophr Res       Date:  2003-05-01       Impact factor: 4.939

7.  Obsessive compulsive symptoms in individuals at clinical risk for psychosis: association with depressive symptoms and suicidal ideation.

Authors:  Jordan E DeVylder; Amy J Oh; Shelly Ben-David; Neyra Azimov; Jill M Harkavy-Friedman; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2012-07-28       Impact factor: 4.939

8.  Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome.

Authors:  Scott W Woods; Alan Breier; Robert B Zipursky; Diana O Perkins; Jean Addington; Tandy J Miller; Keith A Hawkins; Eva Marquez; Stacy R Lindborg; Mauricio Tohen; Thomas H McGlashan
Journal:  Biol Psychiatry       Date:  2003-08-15       Impact factor: 13.382

9.  Evidence for separate diseases?: Stages of one disease or different combinations of symptom dimensions?

Authors:  Heinz Häfner; Wolfram an der Heiden; Kurt Maurer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

10.  Using the brief core schema scales with individuals at clinical high risk of psychosis.

Authors:  Jean Addington; Lisa Tran
Journal:  Behav Cogn Psychother       Date:  2009-03
View more
  6 in total

1.  Stigma related to labels and symptoms in individuals at clinical high-risk for psychosis.

Authors:  Lawrence H Yang; Bruce G Link; Shelly Ben-David; Kelly E Gill; Ragy R Girgis; Gary Brucato; Ahtoy J Wonpat-Borja; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2015-08-25       Impact factor: 4.939

2.  Association between sleep, childhood trauma and psychosis-like experiences.

Authors:  Nicole D Andorko; Zachary B Millman; Elizabeth Klingaman; Deborah Medoff; Emily Kline; Jordan DeVylder; Gloria Reeves; Jason Schiffman
Journal:  Schizophr Res       Date:  2018-03-09       Impact factor: 4.939

3.  Core beliefs in healthy youth and youth at ultra high-risk for psychosis: Dimensionality and links to depression, anxiety, and attenuated psychotic symptoms.

Authors:  Henry R Cowan; Dan P McAdams; Vijay A Mittal
Journal:  Dev Psychopathol       Date:  2018-03-06

4.  Predictors of internalized mental health stigma in a help-seeking sample of youth: The roles of psychosis-spectrum symptoms and family functioning.

Authors:  Joseph S DeLuca; LeeAnn Akouri-Shan; Samantha Y Jay; Samantha L Redman; Emily Petti; Alicia Lucksted; Pamela Rakhshan Rouhakhtar; Mallory J Klaunig; Sarah M Edwards; Gloria M Reeves; Jason Schiffman
Journal:  J Abnorm Psychol       Date:  2021-08

5.  Longitudinal outcome of attenuated positive symptoms, negative symptoms, functioning and remission in people at clinical high risk for psychosis: a meta-analysis.

Authors:  Gonzalo Salazar de Pablo; Filippo Besana; Vincenzo Arienti; Ana Catalan; Julio Vaquerizo-Serrano; Anna Cabras; Joana Pereira; Livia Soardo; Francesco Coronelli; Simi Kaur; Josette da Silva; Dominic Oliver; Natalia Petros; Carmen Moreno; Ana Gonzalez-Pinto; Covadonga M Díaz-Caneja; Jae Il Shin; Pierluigi Politi; Marco Solmi; Renato Borgatti; Martina Maria Mensi; Celso Arango; Christoph U Correll; Philip McGuire; Paolo Fusar-Poli
Journal:  EClinicalMedicine       Date:  2021-06-16

Review 6.  Pivotal mental states.

Authors:  Ari Brouwer; Robin Lester Carhart-Harris
Journal:  J Psychopharmacol       Date:  2020-11-11       Impact factor: 4.153

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.